Literature DB >> 12091174

Lack of association between antibiotic use in the first year of life and asthma, allergic rhinitis, or eczema at age 5 years.

Juan C Celedón1, Augusto A Litonjua, Louise Ryan, Scott T Weiss, Diane R Gold.   

Abstract

Five retrospective studies have reported an association between antibiotic use in early life and asthma in childhood. We studied the relationship between the use of oral antibiotics in the first year of life and asthma, allergic rhinitis, and eczema at age 5 years among 448 children with a parental history of atopy monitored from birth. After adjustment for potential confounders, we found no significant association between antibiotic use in the first year of life and asthma (odds ratio [OR] for one versus no courses of antibiotics, 0.5; 95% confidence interval [CI] for OR, 0.2 to 1.5; OR for two or more versus no courses of antibiotics, 1.0; 95% CI for OR, 0.5 to 2.2), recurrent wheezing, allergic rhinitis, or eczema at age 5 years. There was no significant association between antibiotic use in the first year of life and having at least one of three atopic diseases (asthma, allergic rhinitis, or eczema) at age 5 years (OR for one versus no courses of antibiotics, 0.7; 95% CI, 0.4 to 1.4; OR for two or more versus no courses of antibiotics, 0.9; 95% CI, 0.5 to 1.4). Our findings do not support the hypothesis that antibiotic use in early life is associated with the subsequent development of asthma and atopy in childhood.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091174     DOI: 10.1164/rccm.2109074

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  24 in total

Review 1.  Antibiotics in asthma.

Authors:  David A Beuther; Richard J Martin
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

2.  The early life origins of asthma and related allergic disorders.

Authors:  J O Warner
Journal:  Arch Dis Child       Date:  2004-02       Impact factor: 3.791

Review 3.  Pro and anti: the biotics of allergic disease.

Authors:  J Crane
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

4.  Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood.

Authors:  Catherine Cohet; Soo Cheng; Claire MacDonald; Michael Baker; Sunia Foliaki; Nyk Huntington; Jeroen Douwes; Neil Pearce
Journal:  J Epidemiol Community Health       Date:  2004-10       Impact factor: 3.710

5.  Relation of early antibiotic use to childhood asthma: confounding by indication?

Authors:  Y Su; J Rothers; D A Stern; M Halonen; A L Wright
Journal:  Clin Exp Allergy       Date:  2010-06-07       Impact factor: 5.018

Review 6.  Antenatal risk factors, cytokines and the development of atopic disease in early childhood.

Authors:  E K Chung; R L Miller; M T Wilson; S J McGeady; J F Culhane
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-01       Impact factor: 5.747

Review 7.  The role of the early-life environment in the development of allergic disease.

Authors:  Ganesa Wegienka; Edward Zoratti; Christine Cole Johnson
Journal:  Immunol Allergy Clin North Am       Date:  2014-10-18       Impact factor: 3.479

8.  Early-life antibiotic use and subsequent diagnosis of food allergy and allergic diseases.

Authors:  A G Hirsch; J Pollak; T A Glass; M N Poulsen; L Bailey-Davis; J Mowery; B S Schwartz
Journal:  Clin Exp Allergy       Date:  2016-10-14       Impact factor: 5.018

9.  Recorded infections and antibiotics in early life: associations with allergy in UK children and their parents.

Authors:  Jessica M Harris; Pamela Mills; Carol White; Susan Moffat; Anthony J Newman Taylor; Paul Cullinan
Journal:  Thorax       Date:  2007-02-08       Impact factor: 9.139

10.  Birth by cesarean section, allergic rhinitis, and allergic sensitization among children with a parental history of atopy.

Authors:  Michael Pistiner; Diane R Gold; Hassen Abdulkerim; Elaine Hoffman; Juan C Celedón
Journal:  J Allergy Clin Immunol       Date:  2008-06-20       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.